Clinical trials
Recruiting Neuroblastoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 3 |
| Nanjing First Hospital, Nanjing Medical University | 2 |
| Sichuan University | 2 |
| Sun Yat-Sen University Cancer Center | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Beijing Biotech | 1 |
| Beijing Children's Hospital | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Nanjing Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 19 |
| Recurrence | 4 |
| Paraganglioma | 2 |
| Pheochromocytoma | 2 |
| Desmoplastic Small Round Cell Tumor | 1 |
| Ganglioneuroblastoma | 1 |
| Medulloblastoma | 1 |
| Nasopharyngeal Carcinoma | 1 |
| Neoplasm Metastasis | 1 |
| Neuroendocrine Tumors | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.